
Dung Anh Le
Examiner (ID: 16582, Phone: (571)272-1784 , Office: P/2819 )
| Most Active Art Unit | 2818 |
| Art Unit(s) | 2819, 2818 |
| Total Applications | 2716 |
| Issued Applications | 2558 |
| Pending Applications | 17 |
| Abandoned Applications | 155 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18716455
[patent_doc_number] => 11793776
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-24
[patent_title] => Methods of administering solriamfetol to lactating women
[patent_app_type] => utility
[patent_app_number] => 18/176855
[patent_app_country] => US
[patent_app_date] => 2023-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11691
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18176855
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/176855 | Methods of administering solriamfetol to lactating women | Feb 28, 2023 | Issued |
Array
(
[id] => 18683845
[patent_doc_number] => 11779554
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-10
[patent_title] => Methods of administering solriamfetol to lactating women
[patent_app_type] => utility
[patent_app_number] => 18/176860
[patent_app_country] => US
[patent_app_date] => 2023-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11663
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18176860
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/176860 | Methods of administering solriamfetol to lactating women | Feb 28, 2023 | Issued |
Array
(
[id] => 18664802
[patent_doc_number] => 11771667
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-03
[patent_title] => Methods of administering solriamfetol to lactating women
[patent_app_type] => utility
[patent_app_number] => 18/176816
[patent_app_country] => US
[patent_app_date] => 2023-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11678
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18176816
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/176816 | Methods of administering solriamfetol to lactating women | Feb 28, 2023 | Issued |
Array
(
[id] => 18466861
[patent_doc_number] => 20230201141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => FOOD SUPPLEMENT AND COMPOSITION COMPRISING CHOLINE BUTYRATE SALT AND/OR BUTYRYLCHOLINE
[patent_app_type] => utility
[patent_app_number] => 18/175123
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175123
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175123 | FOOD SUPPLEMENT AND COMPOSITION COMPRISING CHOLINE BUTYRATE SALT AND/OR BUTYRYLCHOLINE | Feb 26, 2023 | Pending |
Array
(
[id] => 18522857
[patent_doc_number] => 20230233506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => METHOD AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF BROAD SPECTRUM VIRUS AILMENTS COMPRISING A CALCIUM CHANNEL BLOCKER OR A CALMODULIN BLOCKER
[patent_app_type] => utility
[patent_app_number] => 18/114305
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18114305
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/114305 | METHOD AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF BROAD SPECTRUM VIRUS AILMENTS COMPRISING A CALCIUM CHANNEL BLOCKER OR A CALMODULIN BLOCKER | Feb 26, 2023 | Abandoned |
Array
(
[id] => 19808257
[patent_doc_number] => 12239616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Food supplement and composition comprising choline butyrate salt and/or butyrylcholine
[patent_app_type] => utility
[patent_app_number] => 18/175142
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8303
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175142
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175142 | Food supplement and composition comprising choline butyrate salt and/or butyrylcholine | Feb 26, 2023 | Issued |
Array
(
[id] => 20031876
[patent_doc_number] => 20250170098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => MOLECULAR JACKHAMMER FOR MECHANICAL DESTRUCTION OF CELLULAR STRUCTURE
[patent_app_type] => utility
[patent_app_number] => 18/841126
[patent_app_country] => US
[patent_app_date] => 2023-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41176
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18841126
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/841126 | MOLECULAR JACKHAMMER FOR MECHANICAL DESTRUCTION OF CELLULAR STRUCTURE | Feb 23, 2023 | Pending |
Array
(
[id] => 18550730
[patent_doc_number] => 20230248730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
[patent_app_type] => utility
[patent_app_number] => 18/171254
[patent_app_country] => US
[patent_app_date] => 2023-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18171254
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/171254 | USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK) | Feb 16, 2023 | Abandoned |
Array
(
[id] => 18565600
[patent_doc_number] => 20230255927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => MONENSIN LEVELS FOR MODERN DAIRY DIET
[patent_app_type] => utility
[patent_app_number] => 18/109410
[patent_app_country] => US
[patent_app_date] => 2023-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10606
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18109410
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/109410 | MONENSIN LEVELS FOR MODERN DAIRY DIET | Feb 13, 2023 | Pending |
Array
(
[id] => 18433456
[patent_doc_number] => 20230180750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => NATURALLY-DERIVED SURFACE SANITIZER AND DISINFECTANT
[patent_app_type] => utility
[patent_app_number] => 18/108985
[patent_app_country] => US
[patent_app_date] => 2023-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18108985
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/108985 | NATURALLY-DERIVED SURFACE SANITIZER AND DISINFECTANT | Feb 12, 2023 | Pending |
Array
(
[id] => 18435931
[patent_doc_number] => 20230183225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => USE OF SELECTIVE GABA A ALPHA 5 NEGATIVE ALLOSTERIC MODULATORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/107741
[patent_app_country] => US
[patent_app_date] => 2023-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18107741
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/107741 | USE OF SELECTIVE GABA A ALPHA 5 NEGATIVE ALLOSTERIC MODULATORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM CONDITIONS | Feb 8, 2023 | Abandoned |
Array
(
[id] => 18403875
[patent_doc_number] => 20230165225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => PREVENTION OF DISEASES IN HONEYBEES AND REDUCTION OF PESTICIDE RESIDUES IN BEESWAX
[patent_app_type] => utility
[patent_app_number] => 18/103541
[patent_app_country] => US
[patent_app_date] => 2023-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6644
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18103541
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/103541 | PREVENTION OF DISEASES IN HONEYBEES AND REDUCTION OF PESTICIDE RESIDUES IN BEESWAX | Jan 30, 2023 | Pending |
Array
(
[id] => 18877429
[patent_doc_number] => 20240000798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => MODULATION OF SOLUBILITY, STABILITY, ABSORPTION, METABOLISM, AND PHARMACOKINETIC PROFILE OF LIPOPHILIC DRUGS BY STEROLS
[patent_app_type] => utility
[patent_app_number] => 18/102136
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18102136
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/102136 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols | Jan 26, 2023 | Issued |
Array
(
[id] => 19650002
[patent_doc_number] => 12171762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Sleep disorder treatment and prevention
[patent_app_type] => utility
[patent_app_number] => 18/152399
[patent_app_country] => US
[patent_app_date] => 2023-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 33055
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18152399
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/152399 | Sleep disorder treatment and prevention | Jan 9, 2023 | Issued |
Array
(
[id] => 18374276
[patent_doc_number] => 20230149354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => METHODS AND COMPOSITIONS INVOLVING BUCINDOLOL FOR THE TREATMENT OF ATRIAL FIBRILLATION
[patent_app_type] => utility
[patent_app_number] => 18/150993
[patent_app_country] => US
[patent_app_date] => 2023-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77265
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -205
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150993
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150993 | Methods and compositions involving bucindolol for the treatment of atrial fibrillation | Jan 5, 2023 | Issued |
Array
(
[id] => 18664801
[patent_doc_number] => 11771666
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-03
[patent_title] => Methods of administering solriamfetol to lactating women
[patent_app_type] => utility
[patent_app_number] => 18/148682
[patent_app_country] => US
[patent_app_date] => 2022-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11644
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18148682
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/148682 | Methods of administering solriamfetol to lactating women | Dec 29, 2022 | Issued |
Array
(
[id] => 18962978
[patent_doc_number] => 11896717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Sustained-release dosage forms of ruxolitinib
[patent_app_type] => utility
[patent_app_number] => 18/090547
[patent_app_country] => US
[patent_app_date] => 2022-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11589
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18090547
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/090547 | Sustained-release dosage forms of ruxolitinib | Dec 28, 2022 | Issued |
Array
(
[id] => 18610757
[patent_doc_number] => 20230277487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => METHODS AND AGENTS THAT ENHANCE MYOGENIC PROGENITOR CELL ENGRAFTMENT
[patent_app_type] => utility
[patent_app_number] => 18/088756
[patent_app_country] => US
[patent_app_date] => 2022-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18088756
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/088756 | Methods and agents that enhance myogenic progenitor cell engraftment | Dec 25, 2022 | Issued |
Array
(
[id] => 19716085
[patent_doc_number] => 12201600
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Treatment of herpes zoster with topical tetracaine
[patent_app_type] => utility
[patent_app_number] => 18/068403
[patent_app_country] => US
[patent_app_date] => 2022-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3806
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18068403
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/068403 | Treatment of herpes zoster with topical tetracaine | Dec 18, 2022 | Issued |
Array
(
[id] => 18829572
[patent_doc_number] => 20230398096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => COMPOSITION COMPRISING TETRACYCLIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/081390
[patent_app_country] => US
[patent_app_date] => 2022-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2864
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18081390
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/081390 | COMPOSITION COMPRISING TETRACYCLIC COMPOUND | Dec 13, 2022 | Abandoned |